| A study to determine bioavailability and safety of ND 10 (7 Methylxanthine a caffeine derivative)Extended Release Tablets 500 mg | An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose,crossover, comparative bioavailability study of ND 10 (7-Methylxanthine, a caffeine derivative)Extended-Release Tablets 500 mg of Theialife Holdings Limited comparing with ND 10 (7-Methylxanthine, a caffeine derivative) Immediate Release Tablets 400 mg of Theialife HoldingsLimited in healthy, adult, human subjects under fasting condition. - NIL | CTRI/2025/04/084974 |
| A study to determine the absorption and safety of ND 10 (7 Methylxanthine a caffeine derivative) Extended Release Tablets 500 mg | An open label single treatment single period single strength twice daily dosing bioavailability study of ND 10 (7 Methylxanthine a caffeine derivative) Extended Release Tablets 500 mg of Theialife Sciences in healthy adult human subjects under fed conditions - NA | CTRI/2024/02/062927 |
| A study to determine bioavailability and safety of ND 10 (7 Methylxanthine a caffeine derivative)Extended Release Tablets 500 mg | An open label balanced randomized two-treatment two-period two-sequence multiple-dose steady state crossover comparative bioavailability study of ND 10 (7-Methylxanthine, a caffeine derivative) Extended-Release Tablets 500 mg of Theialife Sciences comparing with ND 10 (7-Methylxanthine a caffeine derivative) Immediate Release Tablets 400 mg of Theialife Sciences in healthy adult human subjects under fed conditions - NA | CTRI/2024/02/062928 |
| Study on the effect of early methylxanthine therapy on reducing preterm infants’ complications in medical university of shiraz related hospitals | Study on the effect of early methylxanthine therapy on reducing preterm infants’ complications in medical university of shiraz related hospitals | IRCT2013110410441N4 |
| Myopia Progression and the Effect of 7-Methylxanthine | Phase 2 Study of the Effect of 7-Methylxanthine on the Progression of Childhood Myopia | NCT00263471 |
| Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study | Long-Term Effects On Sleep Of Methylxanthine Therapy For Apnea Of Prematurity | NCT01020357 |
